Revista espanola de cardiologia最新文献

{"title":"Predictibilidad y tilting de dispositivo en la reparación mitral de borde a borde","authors":"Chi-Hion Pedro Li , Lluís Asmarats , Albert Massó van Roessel , Helena Capellades , Xavier Millán , Dabit Arzamendi","doi":"10.1016/j.recesp.2025.01.023","DOIUrl":"10.1016/j.recesp.2025.01.023","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 924-926"},"PeriodicalIF":5.9,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181352","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Beneficio pronóstico de la revascularización percutánea de las oclusiones coronarias crónicas. Paradojas y contradicciones de un debate sin final","authors":"Alfonso Jurado-Román , José M. Montero-Cabezas","doi":"10.1016/j.recesp.2025.03.004","DOIUrl":"10.1016/j.recesp.2025.03.004","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 860-862"},"PeriodicalIF":5.9,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Diferencias según el sexo en la anatomía de la insuficiencia mitral y resultados de la reparación percutánea de borde a borde","authors":"Chi-Hion Pedro Li , Lluís Asmarats , Albert Massó van Roessel , Helena Capellades , Estefanía Fernández-Peregrina , Dabit Arzamendi","doi":"10.1016/j.recesp.2025.01.024","DOIUrl":"10.1016/j.recesp.2025.01.024","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 11","pages":"Pages 1010-1012"},"PeriodicalIF":5.9,"publicationDate":"2025-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145369614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Deterioro de la fracción de eyección del ventrículo izquierdo y eventos cardiovasculares en la miocardiopatía con excesiva trabeculación: hacia la medicina de precisión","authors":"Guillem Casas ,&nbsp;Eduard Ródenas-Alesina ,&nbsp;Javier Limeres ,&nbsp;Clara Badia-Molins ,&nbsp;José M. Larrañaga-Moreira ,&nbsp;Jesús G. Mirelis ,&nbsp;Javier Navarrete-Navarro ,&nbsp;Jesús Martín-Jiménez ,&nbsp;Juan E. Alcalá-López ,&nbsp;Josefa González-Carrillo ,&nbsp;Albert Teis ,&nbsp;Rafaela Soler-Fernández ,&nbsp;Gisela Teixidó-Turà ,&nbsp;Laura Gutiérrez-García ,&nbsp;Paula Fernández-Álvarez ,&nbsp;Patricia Muñoz-Cabello ,&nbsp;José A. Barrabés ,&nbsp;Coloma Tirón ,&nbsp;Julián Palomino-Doza ,&nbsp;José Manuel García-Pinilla ,&nbsp;José F. Rodríguez-Palomares","doi":"10.1016/j.recesp.2025.01.005","DOIUrl":"10.1016/j.recesp.2025.01.005","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Defining the probability of cardiomyopathy in individuals with excessive trabeculation of the left ventricle (ETLV) is an unmet clinical need. Our aims were: <em>a)</em> to describe the incidence and predictors of left ventricular ejection fraction (LVEF) decline and its correlation with major adverse cardiovascular events (MACE); and <em>b)</em> to identify prognostic factors in low-risk individuals.</div></div><div><h3>Methods</h3><div>Retrospective multicenter study in patients with ETLV and suspected cardiomyopathy. Two endpoints were analyzed: <em>a)</em> LVEF decline (&gt; 10% absolute decrease in LVEF with LVEF &lt;<!--> <!-->50% at follow-up); and <em>b)</em> MACE, a composite of heart failure, ventricular arrhythmias, systemic embolisms, or cardiovascular mortality. Cardiovascular magnetic resonance core-lab analysis was performed in low-risk individuals (LVEF ≥<!--> <!-->50% and negative late gadolinium enhancement).</div></div><div><h3>Results</h3><div>A total of 530 patients were included, with a mean age of 44<!--> <!-->±<!--> <!-->19 years and 44% were women. The mean LVEF was 49<!--> <!-->±<!--> <!-->16%. Over a median echocardiographic follow-up of 4.2 years, 29 patients (6%) showed a decline in LVEF. Late gadolinium enhancement (<em>P<!--> </em>=<!--> <!-->.004) and baseline atrial fibrillation (<em>P<!--> </em>=<!--> <!-->.006) were independently associated with LVEF decline. During a subsequent clinical follow-up of 3.8 years, 106 patients (20%) experienced MACE. Factors that remained associated with MACE after adjustment were baseline LVEF (<em>P<!--> </em>&lt;<!--> <!-->.001), LVEF decline (<em>P</em> <!-->=<!--> <!-->.022), baseline atrial fibrillation (<em>P</em> <!-->=<!--> <!-->.001), and QRS ≥<!--> <!-->120<!--> <!-->ms (<em>P</em> <!-->=<!--> <!-->.009). Among low-risk individuals, left atrial strain correlated with outcomes and distinguished subclinical cardiomyopathy from physiological excessive trabeculation.</div></div><div><h3>Conclusions</h3><div>In ETLV, a decline in LVEF predicts cardiovascular events beyond baseline LVEF. In low-risk individuals, left atrial strain defines the probability of cardiomyopathy. A comprehensive assessment might provide valuable insights for differential diagnosis and risk stratification in this population.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 11","pages":"Pages 934-944"},"PeriodicalIF":5.9,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145369674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Implante de Impella por tronco braquiocefálico: una alternativa para soporte izquierdo en accesos axilares pequeños","authors":"Enrique Pérez-de la Sota,&nbsp;Andrea Eixerés-Esteve,&nbsp;Jorge Enrique Centeno-Rodríguez,&nbsp;María Jesús López-Gude,&nbsp;Christian Muñoz-Guijosa","doi":"10.1016/j.recesp.2025.02.021","DOIUrl":"10.1016/j.recesp.2025.02.021","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 12","pages":"Pages 1124-1126"},"PeriodicalIF":5.9,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145579129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Migración de un ateroma gravemente calcificado durante el TAVI","authors":"Marta Herrero-Brocal ,&nbsp;Almudena Ureña ,&nbsp;Juan M. Ruiz-Nodar","doi":"10.1016/j.recesp.2025.01.019","DOIUrl":"10.1016/j.recesp.2025.01.019","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 9","pages":"Pages 831-832"},"PeriodicalIF":5.9,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144895213","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"La cardiotoxicidad de las antraciclinas se asocia a alteraciones en la energética de la miosina cardiaca","authors":"Danielle Medina-Hernández ,&nbsp;Carlos Galán-Arriola ,&nbsp;Javier Sánchez-González ,&nbsp;Julien Ochala ,&nbsp;Borja Ibáñez","doi":"10.1016/j.recesp.2025.02.001","DOIUrl":"10.1016/j.recesp.2025.02.001","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 11","pages":"Pages 1012-1014"},"PeriodicalIF":5.9,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145369615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impacto de la amiloidosis en los resultados tras el implante percutáneo de prótesis valvular aórtica","authors":"Luigi Gerra ,&nbsp;Tommaso Bucci ,&nbsp;Ho Man Lam ,&nbsp;Marta Mantovani ,&nbsp;Antonios A. Argyris ,&nbsp;Muath Alobaida ,&nbsp;Kully Sandhu ,&nbsp;Joseph Mills ,&nbsp;Giuseppe Boriani ,&nbsp;Gregory Y.H. Lip","doi":"10.1016/j.recesp.2025.01.018","DOIUrl":"10.1016/j.recesp.2025.01.018","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>Data on the impact of amyloidosis on outcomes after transcatheter aortic valve implantation (TAVI) are limited. The objective of this study was to evaluate the 1-year risk of adverse events post-TAVI in patients with amyloidosis.</div></div><div><h3>Methods</h3><div>Patients undergoing TAVI (between 2005 and 2023) were categorized into 2 groups based on the presence of amyloidosis. The primary outcome was the 1-year risk of a composite endpoint: heart failure (HF), ischemic stroke, pacemaker implantation, acute kidney injury, and all-cause death. Secondary outcomes assessed the individual components of the composite. Propensity score matching was used to balance the groups, and Cox regression was used to assess the risk of adverse outcomes associated with amyloidosis. Composite outcomes were analyzed for early (30-days) and long-term (30-days to 1 year) follow-up.</div></div><div><h3>Results</h3><div>Data from 589 TAVI patients with amyloidosis (mean age 78.9<!--> <!-->±<!--> <!-->8.2 years, 31.9% female) were compared with 52 296 individuals without amyloidosis (mean age 78.1<!--> <!-->±<!--> <!-->8.8 years, 40.3% female). After propensity score matching, patients with amyloidosis had a significantly higher 1-year risk of adverse events (HR, 1.27; 95%CI, 1.08-1.49). Specifically, patients with amyloidosis showed an increased risk of HF (HR, 1.37; 95%CI, 1.10-1.70). Stroke risk (HR, 1.67; 95%CI, 1.16–2.40) and pacemaker implantation (HR, 2.25; 95%CI, 1.15-4.41) were higher during long-term follow-up, while no differences were found for acute kidney injury or all-cause mortality between the 2 groups.</div></div><div><h3>Conclusions</h3><div>Among patients undergoing TAVI, those with amyloidosis are at a higher risk of adverse events, particularly HF, and have an increased risk of pacemaker implantation and stroke in the long-term.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 886-895"},"PeriodicalIF":5.9,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Intervención en la dieta mediterránea y evolución de la placa coronaria tras síndrome coronario agudo. El ensayo clínico MEDIMACS","authors":"Ana I. Fernández-Ávila ,&nbsp;Enrique Gutiérrez-Ibañes ,&nbsp;Álvaro Gabaldón ,&nbsp;Josep Gómez-Lara ,&nbsp;Miguel Ángel Martínez-González ,&nbsp;Javier Bermejo ,&nbsp;en representación de los investigadores del estudio MEDIMACS ,&nbsp;Irene Martín de Miguel ,&nbsp;Ricardo Sanz-Ruiz ,&nbsp;Elena Jurado ,&nbsp;Francisco Fernández-Avilés ,&nbsp;Cristina Razquin Burillo ,&nbsp;Rafael de la Torre ,&nbsp;Pablo Martínez-Legazpi ,&nbsp;Raquel Yotti ,&nbsp;Alex Mira ,&nbsp;Uri Gophna ,&nbsp;Roger Karlsson ,&nbsp;Reem Al-Daccak ,&nbsp;Dominique Charron","doi":"10.1016/j.recesp.2025.01.008","DOIUrl":"10.1016/j.recesp.2025.01.008","url":null,"abstract":"","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 9","pages":"Pages 822-825"},"PeriodicalIF":5.9,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144895223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Identificación de fenotipos en la insuficiencia cardiaca con fracción de eyección conservada a partir de 8.161 pacientes de 3 cohortes españolas","authors":"Òscar Miró ,&nbsp;Olivier Peyrony ,&nbsp;Joan Carles Trullàs ,&nbsp;Aitor Alquézar-Arbé ,&nbsp;Julio Núñez ,&nbsp;Pedro López-Ayala ,&nbsp;Javier Jacob ,&nbsp;Héctor Bueno ,&nbsp;Manuel Montero-Pérez-Barquero ,&nbsp;José Carlos Arévalo-Lorido ,&nbsp;Rafael de la Espriella ,&nbsp;Gema Miñana ,&nbsp;Juan Sanchis ,&nbsp;Pere Llorens","doi":"10.1016/j.recesp.2025.02.019","DOIUrl":"10.1016/j.recesp.2025.02.019","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>To identify phenotypes in heart failure with preserved ejection fraction (HFpEF), compare mortality, and investigate whether treatments have different effects according to phenotype.</div></div><div><h3>Methods</h3><div>We performed a secondary analysis of 8161 patients with HFpEF included in Spanish cardiology (INCLIVA), internal medicine (RICA), and emergency (EAHFE) registries. Phenotypic clusters based on 16 baseline characteristics were identified using latent class analysis. We analyzed crude and treatment-adjusted 1-year survival, the associations between each treatment and mortality, and their interactions with phenotype.</div></div><div><h3>Results</h3><div>We identified 4 distinct clusters. One-year mortality was 18.7%. Cluster 4 (younger women with a valvular heart disease phenotype) had the lowest mortality (13.7%; reference category), which increased progressively in cluster 2 (cardiometabolic phenotype; mortality: 15.7%; adjusted HR, 1.28; 95%<span>C</span>I, 1.06-1.54), cluster 3 (very elderly female phenotype; mortality: 20.4%; adjusted HR, 1.63; 95%CI, 1.40-1.90), and cluster 1 (male cardiorespiratory phenotype; mortality: 24.0%; adjusted HR, 1.81; 95%CI, 1.53-2.13). The results were very similar when each registry was analyzed individually. Treatment with renin-angiotensin system inhibitors was associated with better survival in all clusters, beta-blockers were beneficial in cluster 1, and anticoagulants in cluster 4. However, none of the treatments showed a differential association with prognosis according to phenotype.</div></div><div><h3>Conclusions</h3><div>This study defines 4 HFpEF phenotypes with significantly different prognoses. Among the treatments analyzed, only renin-angiotensin system inhibitors seemed to have a generalized survival benefit, and none demonstrated a differential effect based on phenotype.</div></div>","PeriodicalId":21299,"journal":{"name":"Revista espanola de cardiologia","volume":"78 10","pages":"Pages 896-905"},"PeriodicalIF":5.9,"publicationDate":"2025-03-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145181402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}